Screening for Duchenne muscular dystrophy in newborns in the Ningxia region

OBJECTIVES: To evaluate the incidence rate of Duchenne muscular dystrophy (DMD) in the male newborns in the Ningxia region and establish a critical threshold for screening DMD in newborns to distinguish between the normal population and affected individuals.

METHODS: A total of 10 000 male newborns were screened using immunofluorescence analysis of creatine kinase isoenzyme concentrations in heel spot dried blood specimens. Newborns with the concentrations higher than the critical threshold were recalled for serum creatine kinase measurements. Genetic testing was performed to confirm diagnosis in cases showing abnormalities.

RESULTS: Among the screened 10 000 male newborns, two were confirmed to have DMD through genetic testing, resulting in a preliminary estimated incidence rate of 1/5 000 for male newborns in the Ningxia region. The critical threshold for creatine kinase isoenzyme concentration in newborns in this region was determined to be 468.57 ng/mL.

CONCLUSIONS: Screening for DMD in newborns is feasible in the Ningxia region. Early screening, diagnosis, and treatment of DMD can improve the quality of life for affected individuals and help families make informed decisions regarding further pregnancies.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:26

Enthalten in:

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics - 26(2024), 3 vom: 15. März, Seite 258-261

Sprache:

Chinesisch

Weiterer Titel:

宁夏地区新生儿杜氏肌营养不良症筛查

Beteiligte Personen:

Jing, Miao [VerfasserIn]
Wang, Yue [VerfasserIn]
Jing, Xiao-Ying [VerfasserIn]
Mao, Xin-Mei [VerfasserIn]

Links:

Volltext

Themen:

Creatine Kinase
Creatine kinase isoenzyme
Critical threshold
Duchenne muscular dystrophy
EC 2.7.3.2
English Abstract
Incidence rate
Isoenzymes
Journal Article
Newborn
Screening

Anmerkungen:

Date Completed 03.04.2024

Date Revised 04.04.2024

published: Print

Citation Status MEDLINE

doi:

10.7499/j.issn.1008-8830.2309151

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370468805